Barrett JR, Rendell V, Pokrzywa C, Lopez-Aguiar AG, et al. Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit. J Surg Oncol 2020;121:1067-1073.
PMID: 32153032